Search clinical trials for: CCR5 Receptor Antagonists

Total 37770 results

Otsuka Pharmaceutical Development & Commercialization...

Completed

Oral Aripiprazole Open-Label Rollover Study

Schizophrenia

Russian Federation, Argentina, Croatia, India, Serbia, Ukraine
Korea Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.

Completed

Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder

Tourette's Disorder | Chronic Motor or Vocal Tic Disorder

Korea, Republic of
University of Sao Paulo

Unknown

Potentiation of Quetiapine Treatment With Lithium or Aripiprazole in Bipolar 1 Nonresponders Patients (ARIQUELI)

Bipolar I Disorder

Brazil
Otsuka Pharmaceutical Development & Commercialization...

Completed

Aripiprazole Open-Label, Safety and Tolerability Study (APEX 241)

Schizophrenia | Bipolar Disorder

United States
Massachusetts General Hospital
Bristol-Myers Squibb

Completed

The Combination of Aripiprazole and Antidepressants in Psychotic Major Depression (Abilify)

Psychotic Depression

United States
Louisiana State University Health Sciences Center...
Bristol-Myers Squibb

Terminated

Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS)

Schizophrenia | Schizoaffective Disorder

United States
Lindner Center of HOPE
University of Cincinnati

Completed

A Preliminary Study of the Effectiveness and Tolerability of Aripiprazole in Bipolar Depression

Bipolar Depression

United States
AstraZeneca

Completed

Drug Interaction Study Between AZD3480 and Aripiprazole in Healthy Subjects

Alzheimer's Disease

Sweden
Taoyuan Psychiatric Center, Ministry of Health...
Department of Health

Unknown

Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia

Dyskinesia, Drug-Induced

Taiwan
Taiwan Otsuka Pharm. Co., Ltd

Completed

Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia

Schizophrenia | Schizoaffective Disorder

Taiwan
Federal University of São Paulo

Completed

Aripiprazole in the Treatment of Post-Traumatic Stress Disorder Symptoms (AripipPTSD)

Posttraumatic Stress Disorder
Actelion

Terminated

Clinical Study on the Safety and Tolerability of Macitentan in Combination With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma

Glioblastoma

United States
Huazhong University of Science and Technology

Unknown

The Effect of Long-acting Antipsychotics on Schizophrenia Patients With Violence Risk

Schizophrenia

China
Pfizer

Terminated

A Study To Evaluate The Efficacy Of Eplerenone Compared With Losartan For The Treatment Of Patients With Mild To Moderate Hypertension

Hypertension

Taiwan
University of Southampton

Completed

Effect of Clopidogrel on Allergen Challenge in Asthma

Asthma

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

Cangrelor Neonatal PK/PD and Safety Study

Partial Obstruction of Systemic to Pulmonary Artery Shunt | Complete Obstruction of Systemic to Pulmonary Artery Shunt

United States
Scripps Health
National Center for Research Resources (NCRR)

Completed

Pilot Study on the Effect of High Clopidogrel Maintenance Dosing (PREDICT)

Coronary Artery Disease

United States
Eli Lilly and Company

Completed

A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of Clopidogrel

Major Depressive Disorder

United States
National Institute of Diabetes and Digestive and...
Boston University; Washington University School of Medicine; University of Alabama... and other collaborators

Completed

Clopidogrel Prevention of Early Arteriovenous (AV) Fistula Thrombosis (FISTULA)

Kidney Failure | Hemodialysis Fistula Thrombosis

United States
Ottawa Heart Institute Research Corporation

Completed

Transition From Ticagrelor to Clopidogrel Following Acute Coronary Syndrome: To Bolus or Not?

Acute Coronary Syndrome

Canada
Boehringer Ingelheim

Completed

Influence of Clopidogrel on the Pharmacodynamics and Safety of Fradafiban in Healthy Male Subjects

Healthy
Boehringer Ingelheim

Completed

Influence of Clopidogrel on the Pharmacodynamics and Safety of Terbogrel in Healthy Male Subjects

Healthy
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting Conditions

Fasting

Canada
University Hospital Tuebingen

Completed

Mirror Trial - Follow-Up Management of Peripheral Arterial Intervention With Clopidogrel

Peripheral Vascular Diseases

Germany
Sanofi
Bristol-Myers Squibb

Completed

PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metabolic Syndrome

Metabolic Syndrome x

United States
Charles University, Czech Republic

Completed

Clopidogrel Only Before Percutaneous Coronary Intervention or Before Every Coronarography?

Ischemic Heart Disease

Czech Republic
Sun Yat-sen University

Active, not recruiting

Study of Tumor Infiltrating Lymphocytes Following CCRT in the Treatment of Patients With Cervical Carcinoma (TIL-Cx)

Cervical Carcinoma

China
Chinook Therapeutics U.S., Inc.

Active, not recruiting

Atrasentan in Patients With Proteinuric Glomerular Diseases (AFFINITY)

Diabetic Kidney Disease | Focal Segmental Glomerulosclerosis | Immunoglobulin A Nephropathy | IgA Nephropathy | Diabetic Nephropathy Type 2 | Alport Syndrome

United States, Spain, Korea, Republic of, Australia, Italy, United Kingdom
Universita degli Studi di Genova
Università degli Studi della Campania Luigi Vanvitelli

Recruiting

Intravenous CAngrelor in High-bleeding Risk Patients Undergoing percutaneouS Coronary Intervention (ICARUS) Registry (ICARUS)

Myocardial Infarction | Coronary Artery Disease | Bleeding

Italy
Federico II University

Recruiting

Pharmacodynamic Effects of Cangrelor in ACS or CCS Patients Undergoing PCI (POMPEII Registry) (POMPEII)

Percutaneous Coronary Intervention

Italy
The University of The West Indies

Completed

clOpidogrel "resIstaNce" in a Selected Population of Patients at a Tertiary Cardiovascular Center in Trinidad (POINT)

Platelet Dysfunction

Trinidad and Tobago
Fundacion para la Formacion e Investigacion Sanitarias...

Unknown

Impact of Renal Function on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients (Ticagrelor)

Coronary Artery Disease

Spain
Fondazione Evidence per Attività e Ricerche Cardiovascolari...

Terminated

Second Generation" Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month - Dual Antiplatelet Therapy

Angina Pectoris | Silent Ischemia

Italy
Hopital du Sacre-Coeur de Montreal

Completed

Effect of Different Dosing Regimens of Clopidogrel Before Elective Percutaneous Coronary Intervention (PCI) on Platelet Function

Coronary Artery Disease

Canada
Sanofi
Bristol-Myers Squibb

Completed

ALBION "Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis"

Ischemia
R&D Cardiologie

Completed

Platelet Inhibition and Transcranial Doppler (TCD)-Detected Microemboli During and After Carotid Artery Stenting (CAS) in Asymptomatic Patients Prior to Cardiac Surgery (IMPACT)

Carotid Stenosis

Netherlands
University of Cologne

Completed

Effects of Clopidogrel on Blood Pressure

Blood Pressure | Endothelial Function | Platelet Function

Germany, Netherlands
Shenyang Northern Hospital

Completed

Clopidogrel Maintaining Dosage in Acute Coronary Syndrome After Drug Eluting Stent Implantation

Acute Coronary Syndrome
AbbVie (prior sponsor, Abbott)

Completed

Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor (RADAR)

Diabetic Nephropathy | Chronic Kidney Disease

United States, Canada, Puerto Rico, Taiwan
National Institute of Allergy and Infectious Diseases...
AIDS Clinical Trials Group; HIV Prevention Trials Network

Completed

Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women

HIV Infection

United States, Puerto Rico
Guy's and St Thomas' NHS Foundation Trust
Gilead Sciences; ViiV Healthcare

Completed

The Role of Home Packs of HIV PEPSE in High Risk Individuals (Home PEPSE)

HIV-1-infection

United Kingdom
Garden State Infectious Disease Associates, PA
GlaxoSmithKline

Completed

An Interaction Study to Assess Drug Levels in Healthy Adult Subjects

Healthy

United States
Medical University of Vienna

Completed

Endothelin-Receptor Blockade in Coronary Heart Disease

Vascular Resistance | Coronary Vessels | Endothelins

Austria
Assistance Publique Hopitaux De Marseille

Recruiting

TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome. (TROUPER)

Acute Coronary Syndrome

France
University Hospitals Cleveland Medical Center

Completed

Inflammation and Thrombosis in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement (TAVR)

Inflammation | Thrombosis | Aortic Stenosis

United States
Madrigal Pharmaceuticals, Inc.

Completed

Drug Interaction Study of MGL-3196 With Clopidogrel

Healthy

United States
Laboratoires Teriak

Completed

Incidence of Major Cardiovascular Events in Diabetic Patients With ACS Undergoing Coronary Angioplasty and Treated With Clopidogrel 150 mg Versus 75 mg (IDASCOP 1)

Diabetes Mellitus, Type 2 | Coronary Angioplasty | NSTEMI - Non-ST Segment Elevation MI

Tunisia
University of Southern California

Completed

Switch to Ticagrelor in Critical Limb Ischemia Anti-platelet Study (STT-CLIPS)

Critical Limb Ischemia

United States
Akcea Therapeutics

Completed

Drug-drug Interaction Study to Evaluate the Effect of ISIS 681257 on Clopidogrel

Cardiovascular Diseases | Elevated Lipoprotein(a)

Canada
Dong-A University
AstraZeneca; Biotronik SE & Co. KG

Completed

Comparing Ticagrelor Versus Clopidogrel on Microcirculation (PLEIO)

Acute Coronary Syndrome

Korea, Republic of

Search clinical trials for: CCR5 Receptor Antagonists

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations